Vanguard Capital Management’s RenovoRx RNXT Stock Holding History
Bought
Maintained
Sold
Other funds holding RNXT
ACM
Vanguard Capital Management's RNXT Position: Q3 2026 in Review
Vanguard Capital Management increased its RenovoRx (RNXT) stake by 16% in Q3 2026, buying an estimated $300K and bringing the position to 1,668,360 shares worth $2.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3294.
Vanguard Capital Management first reported a position in RNXT in Q1 2026 and has held it in 3 quarters since. 40 funds tracked by Wall St. Rank hold RNXT as of Q3 2026.
- Vanguard Capital Management held 1,668,360 shares of RenovoRx worth $2.6M as of Q3 2026.
- Vanguard Capital Management bought 224,618 RenovoRx shares in Q3 2026, an estimated $300K.
- RenovoRx made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3294 holding.
- Vanguard Capital Management first reported a position in RenovoRx in Q1 2026 and has held it in 3 quarters since.
- 40 funds tracked by Wall St. Rank held RenovoRx as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.